CAD 0.43
(6.25%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 403.53 Thousand CAD | 310.23% |
2022 | 132.76 Thousand USD | 1070.47% |
2021 | 11.34 Thousand CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 98.33 Thousand USD | 35.32% |
2024 Q2 | 246.31 Thousand USD | 150.49% |
2023 Q2 | 134.36 Thousand USD | 21.89% |
2023 Q1 | 110.23 Thousand USD | 42.02% |
2023 FY | 544.64 Thousand CAD | 310.23% |
2023 Q4 | 72.66 Thousand USD | -15.77% |
2023 Q3 | 86.26 Thousand USD | -35.8% |
2022 Q3 | 55.88 Thousand CAD | 186.07% |
2022 Q1 | - CAD | -100.0% |
2022 Q2 | 19.53 Thousand CAD | 0.0% |
2022 FY | 132.76 Thousand USD | 1070.47% |
2022 Q4 | 77.62 Thousand USD | 38.9% |
2021 Q1 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q4 | 11.34 Thousand CAD | 0.0% |
2021 FY | 11.34 Thousand CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Therma Bright Inc. | 23.89 Thousand CAD | -1588.493% |
Theralase Technologies Inc. | 1.07 Million CAD | 62.297% |
VentriPoint Diagnostics Ltd. | 49.18 Thousand CAD | -720.473% |